Theriva Biologics (TOVX) Shares Issued (2017 - 2026)
Theriva Biologics (TOVX) posted quarterly Shares Issued of $651095.0 for Q1 2026, up 8388.85% year-over-year from $7670.0 in Q1 2025, and down 41.58% quarter-over-quarter from $1.1 million in Q4 2025.
Theriva Biologics (TOVX) Shares Issued (2017 - 2026) Analysis & Trends
Theriva Biologics (TOVX) has reported Shares Issued for 10 consecutive years, with $651095.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued rose 8388.85% year-over-year to $651095.0; the TTM figure through Mar 2026 stood at $651095.0 (up 8388.85% YoY), while the FY2025 annual figure was $1.1 million, up 536.69% from the prior year.
- Shares Issued eased to $651095.0 in Q1 2026 per TOVX's latest filing, from $1.1 million in the prior quarter.
- Across five years, Shares Issued topped out at $6.1 million in Q1 2022 and bottomed at $7566.0 in Q2 2025.
- Historically, Shares Issued has averaged $1.3 million across 5 years, with a median of $238853.0 in 2022.
- Annual changes were most pronounced in 2025 — Shares Issued tumbled 99.82% — and 2026, when it soared 8388.85%.
- Theriva Biologics' Shares Issued stood at $91862.0 in 2022, then soared by 90.56% to $175049.0 in 2023, then slipped by 0.01% to $175034.0 in 2024, then jumped by 536.69% to $1.1 million in 2025, then tumbled by 41.58% to $651095.0 in 2026.
- Business Quant data shows TOVX's Shares Issued at $651095.0 in Q1 2026, $1.1 million in Q4 2025, and $7566.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Theriva Biologics | 10.64 Mn | 10.64 Mn | - | 16.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.58 Mn |
| Jun 30, 2026 | 2.58 Mn |
| Mar 31, 2026 | 651,095.00 |
| Mar 31, 2026 | 651,095.00 |
| Dec 31, 2025 | 1.11 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 7,566.00 |
| Sep 30, 2025 | 7,566.00 |
| Jun 30, 2025 | 7,566.00 |
| Jun 30, 2025 | 7,566.00 |
| Mar 31, 2025 | 7,670.00 |
| Mar 31, 2025 | 7,670.00 |
| Dec 31, 2024 | 175,034.00 |
| Dec 31, 2024 | 175,034.00 |
| Sep 30, 2024 | 175,207.00 |
| Sep 30, 2024 | 175,207.00 |
| Jun 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | 4.18 Mn |
| Mar 31, 2024 | 4.18 Mn |